Preemptive living donor kidney transplantation: Access, fate, and review of the status in Egypt

Table 3 A comparison of the variables affecting the achievement (n = 59) and non-achievement (n = 245) of kidney transplantation in our center, n (%)

Variables		Achievement, n = 59	Non-achievement, n = 245	P value
Age in yr, mean ± SD (range)		29 ± 9.9 (13-57)	32.8 ± 11.9 (12-66)	0.034
Sex
Male		56 (94.9)	179 (73.1)	< 0.001
Female		3 (5.1)	66 (26.9)
Dialysis status
Preemptive access		4 (6.8)	28 (11.4)	0.354
On regular dialysis		55 (93.2	217 (88.6)
Primary kidney disease
Unknown causes		41 (69.5)	202 (82.4)	0.008
Systemic diseases		3 (5.1)	18 (7.4)
Renal diseases		15 (25.4)	25 (10.2)
Number of potential donors per patient1
Donor unavailability		0 (0)	44 (18)	0.003
One donor		43 (72.9)	161 (65.7)
Two donors		13 (22)	31 (12.6)
Three donors		3 (5.1)	9 (3.7)
Outcome of donor evaluation1
Accepted		48 (81.4)	51 (32.9)	< 0.001
Excluded		0 (0)	100 (64.5)
Excluded and accepted		11 (18.6)	4 (2.6)
Number of not-evaluated donors per patient1
One donor		4 (100)	51 (86.4)	> 0.999
Two donors		0 (0)	7 (11.9)
Three donors		0 (0)	1 (1.7)
Chronological order of accepted donor1		n = 59	n = 55
First		48 (81.4)	49 (89.1)	0.596
Second		8 (13.6)	4 (7.3)
Third		3 (5.1)	2 (3.6)
Age of accepted donors, mean ± SD (range)		40.2 ± 10.9 (21-60)	40.5 ± 9.5 (26-58)	0.937
Degree of relatedness of accepted donors1
First		34 (57.6)	26 (47.3)	0.339
Second		20 (33.9)	25 (45.4)
Third		3 (5.1)	4 (7.3)
Unrelated		2 (3.4)	0 (0)
Sex of accepted donor1
Male		20 (33.9)	21 (38.2)	0.779
Female		39 (66.1)	34 (61.8)
Number of excluded donors per patient1		n = 11	n = 102
One donor		8 (72.7)	82 (80.4)	0.572
Two donors		3 (27.3)	17 (16.7)
Three donors		0 (0)	3 (2.9)
Main causes of donor exclusion1		n = 9	n = 100
Medical causes		5 (55.6)	47 (47)	0.462
Immunologic mismatches		2 (22.2)	39 (39)
Combined medical and immunologic causes		2 (22.2)	14 (14)

¹The values and percentages of the donors are not complementary to the total number of patients, because there were multiple donors for 56 patients who had overlapping outcomes of evaluation and fate.

SD: Standard deviation.